This shows a pressing need for not only improved preventive and detection methods, but also for treatment options. Cancer treatments such as chemotherapy, immunotherapy and radiation therapy still face several challenges . Although various single drug pathway-inhibitors have been developed, cancerous cells, specifically found in solid tumors, are known to have a high resistance to drug treatment allowing the disease to recur . Currently, the most effective strategy to overcome drug resistance in oncology treatments consists of administering a combination of drugs rather than a single drug , resulting in a multi-target therapy that takes advantage of the multifactorial nature of cancer.